About Nucleus Formulation
Nucleus Formulation is a company based in Gandhinagar (India) founded in 2009 by Jayesh Pandya. It operates as a B2B and Export. The company has 13 employees as of March 31, 2024. Nucleus Formulation offers products and services including Analgesic Products, Anti-Fungal Products, Cardiovascular Products, Gastro-Intestinal Products, and Gynecology Supplements. Nucleus Formulation operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Gandhinagar, India
- Employees 13 as on 31 Mar, 2024
- Founders Jayesh Pandya
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Nucleus Formulation Private Limited
- Date of Incorporation 13 Jul, 2009
- Jurisdiction Chhatral, Gujarat, India
-
Annual Revenue
$592.6 K (USD)-25.66as on Mar 31, 2024
-
Net Profit
$14.08 K (USD)-39.83as on Mar 31, 2024
-
EBITDA
$60.96 K (USD)-47.29as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
13
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nucleus Formulation
Nucleus Formulation offers a comprehensive portfolio of products and services, including Analgesic Products, Anti-Fungal Products, Cardiovascular Products, Gastro-Intestinal Products, and Gynecology Supplements.
Medications for relieving pain and inflammation.
Treatments against fungal infections.
Formulations for managing cardiovascular conditions.
Solutions for gastrointestinal disorders.
Supplements for gynecological needs.
Funding Insights of Nucleus Formulation
Detailed funding history for Nucleus Formulation
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nucleus Formulation
Investment portfolio details for Nucleus Formulation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nucleus Formulation
Detailed financials for Nucleus Formulation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nucleus Formulation Comparisons
Peer comparison for Nucleus Formulation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nucleus Formulation
Nucleus Formulation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Nucleus Formulation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nucleus Formulation
Complete news archive for Nucleus Formulation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nucleus Formulation
Nucleus Formulation was founded in 2009.
Nucleus Formulation is headquartered in Gandhinagar, India. It is registered at Gandhinagar, Gujarat, India.
As of Mar 31, 2024, the latest employee count at Nucleus Formulation is 13.
Annual revenue of Nucleus Formulation is $592.6K as on Mar 31, 2024.
Nucleus Formulation Pvt. Ltd. is a leading pharmaceutical company based in Gujarat, India, specializing in manufacturing tablets, capsules, and other formulations for areas like diabetology, pain management, and anti-infectives. They operate through contract manufacturing and exports, serving markets in Africa, Asia, and South America while maintaining high safety and quality standards. Their global presence includes partnerships in emerging markets, focusing on generic drugs and therapeutic solutions.
Nucleus Formulation's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Nucleus Formulation offers Analgesic Products, Anti-Fungal Products, Cardiovascular Products, Gastro-Intestinal Products, and Gynecology Supplements.